mis-sense change (G84E) in HOXB13 was found overall in 1.4% of prostate cancer cases and in 0.1% of unaffected controls
mis-sense change (G84E) in HOXB13 was found overall in 1.4% of prostate cancer cases and in 0.1% of unaffected controls
http://www.ncbi.nlm.nih.gov/pubmed/22236224
This entry was posted on December 20, 2013 at 4:58 am and is filed under SciLit.
Tags: cancer, ncvarg, rarevariant, rvas
Best to comment on twitter via @markgerstein. Only use this space for comments that are untweetable!